Introduction
It is generally accepted that myofibroblasts represent key players in the physiological reconstruction of connective tissue after injury and in generating the pathological tissue deformations that characterize fibrosis (Gabbiani, 2003; Desmouliere et al., 2005) . In previous reviews, we have focused on the role of cell-cell and cell-matrix contacts in myofibroblast development and function (Hinz and Gabbiani, 2003a, b; Hinz, 2006) . Here, I draw a more general picture how the mechanical and chemical microenvironments integrate to promote tissue remodeling by myofibroblast. Differentiation of fibroblasts into myofibroblasts can be understood as a two-step process: (1) to re-populate damaged tissues, fibroblasts acquire a migratory phenotype by de novo developing contractile bundles. These in vivo stress fibers are first composed of cytoplasmic actins and generate comparably small traction forces (Hinz et al., 2001b) . We have recently proposed the term ''proto-myofibroblast'' to discriminate such activated fibroblasts from quiescent fibroblasts that are devoid of any contractile apparatus in most intact tissues (Tomasek et al., 2002) . This first phenotypic change occurs in response to changes in the composition, organization, and mechanical property of the extracellular matrix (ECM) (Hinz and Gabbiani, 2003b) and to cytokines locally released by inflammatory and resident cells (Werner and Grose, 2003) . (2) With increasing stress in the ECM resulting from their own remodeling activity, proto-myofibroblasts further develop into ''differentiated myofibroblasts'' by neo-expressing asmooth muscle actin (a-SMA), the most widely used myofibroblast marker. Expression of a-SMA is precisely controlled by the joint action of growth factors like transforming growth factor (TGFb1), of specialized ECM proteins like the fibronectin (FN) splice variant ED-A FN, and of the mechanical microenvironment (Tomasek et al., 2002) . Incorporation of a-SMA into stress fibers significantly augments the contractile activity of fibroblastic cells and hallmarks the contraction phase of connective tissue remodeling (Hinz et al., 2001a) .
It has to be noted that the contribution of myofibroblast contraction to physiological tissue remodeling has been questioned by a study reporting normal closure of pig full thickness wounds despite repeated excision of the central and peripheral granulation tissue (Gross et al., 1995) . However, rat wounds that were kept open for 10 days with a plastic frame and have then been released from the splint contract to B50% of their initial size within 6 hours; this cannot be explained by enhanced proliferation of fibroblasts and keratinocytes at the wound edge. Hence, the porcine skin may be able to compensate for the experimentally induced chronic loss of granulation tissue by mechanisms that have not yet been elucidated. Such a compensatory mechanism appears to function in a-SMAknockout mice that macroscopically exhibit almost normal wound closure (personal communication, J.J. Tomasek, University of Oklahoma Health Sciences Center, Oklahoma City, OK). These mice appear to substitute for a-SMA by de novo expressing other muscle actin isoforms like g-smooth muscle and a-skeletal actin, which also explains why blood pressure is surprisingly little affected by the lack of a-SMA in vascular smooth muscle cells (SMCs) (Schildmeyer et al., 2000) . In contrast to these chronic conditions, acute inhibition of myofibroblast contraction by intracellular delivery of the specific N-terminal sequence AcEEED of a-SMA significantly reduces wound contraction . It will be interesting to test whether conditional a-SMA-knockout mice or mice treated with a-SMA RNAi will exhibit similarly impaired wound closure.
In physiological remodeling such as during dermal wound healing, the contractile activity of myofibroblasts is terminated when the tissue is repaired; a-SMA expression then decreases and myofibroblasts disappear by apoptosis (Desmouliere et al., 1995) . In pathological wound healing, however, myofibroblast activity persists and leads to tissue deformation, which is particularly evident in hypertrophic scars developing after burn injury, in the fibrotic phase of scleroderma and in the palmar fibromatosis of Dupuytren's disease (Schurch et al., 2006) . Myofibroblast-generated contractures are also characteristic for fibrosis affecting vital organs such as the liver (Desmouliere et al., 2003) , heart (Virag and Murry, 2003; Brown et al., 2005) , lung (Phan, 2002; Thannickal et al., 2004) , and kidney (Lan, 2003) . In addition, myofibroblast participation to the process called stroma reaction promotes cancer progression by creating a stimulating microenvironment for epithelial tumor cells (De Wever and Mareel, 2003; Desmouliere et al., 2004) . It becomes increasingly accepted that stroma cells represent important targets of anticancer treatments (Bissell and Radisky, 2001; Liotta and Kohn, 2001; Mueller and Fusenig, 2004) . In the light of such severe consequences of myofibroblast appearance and dysfunction, the necessity of more profoundly understanding the molecular mechanisms of myofibroblast formation and function appears clear.
Myofibroblast origin
The classical view on dermal wound healing implies local recruitment of fibroblasts from the dermis of the intact adjacent skin to sites of inflammation (Desmouliere et al., 2005) . Pericytes and SMC from the vasculature have been proposed as another local myofibroblast source in scleroderma (Rajkumar et al., 2005) as well as liver and glomerular fibrosis (Desmouliere et al., 2003) . In addition, fibroblasts may originate from fibrocytes, a sub-population of bone marrow-derived leukocytes with fibroblast characteristics (Abe et al., 2001) . This concept has recently been revisited by transplanting bone marrow from (1) male to irradiated female mice and identifying the Y chromosome by in situ hybridization (Direkze et al., 2003) and (2) from transgenic green fluorescent mice to irradiated wild-type animals (Hashimoto et al., 2004) . These studies reveal a surprisingly high fraction of 30-50% of the wound myofibroblasts potentially deriving from fibrocyte progenitors (Direkze et al., 2003; Ishii et al., 2005; Mori et al., 2005) . Comparable proportions have been demonstrated for myofibroblasts appearing during fibrosis of the liver (Forbes et al., 2004) , kidney (Direkze et al., 2003) , and lung (Hashimoto et al., 2004) and during the stroma reaction to epithelial tumors (Ishii et al., 2003) . It remains to be seen whether myofibroblasts from different origins exhibit different characteristics and functions during tissue repair as suggested for liver fibrosis (Guyot et al., 2006) or whether the organism is recruiting myofibroblast precursors from several sources to satisfy the temporarily high demand of contractile cells, which may all follow a similar differentiation program.
Identification of the myofibroblast -a warrant
The question of the myofibroblast origin is closely related to the problem of its identification. Three major ultrastructural features discriminate myofibroblasts from quiescent fibroblasts in tissues: (1) bundles of contractile microfilaments, (2) extensive cell-to-matrix attachment sites, and (3) intercellular adherens and gap junctions (Eyden, 2005; Schurch et al., 2006) . However, this definition has its limits when myofibroblasts need to be discriminated from other contractile cell types like SMC, requiring specific molecular markers.
Cytoskeletal markers of the myofibroblast. The most frequently employed myofibroblast marker is a-SMA, which evidently fails to distinguish between myofibroblasts and SMC in situations that exhibit mixed populations. For example, remodeling of injured arteries is thought to be predominantly driven by SMC from the media but a contribution from adventitial fibroblasts has also been suggested (Sartore et al., 2001; Zalewski et al., 2002) . Contractile SMC specifically express smooth muscle myosin heavy chain, h-caldesmon, and desmin; however, SMC loose these markers when acquiring a synthetic phenotype and after being placed in culture (Christen et al., 2001) . Until recently, smoothelin was suggested a late differentiation marker for SMC that is not expressed in myofibroblasts (van der Loop et al., 1996) . However, gene expression profiling supported by protein biochemistry revealed induction of smoothelin and other late SMC markers in TGFb1-treated cultured lung fibroblasts (Chambers et al., 2003) . Very recently, the 4Ig isoform of the stress fiber protein palladin has been proposed as novel marker for myofibroblast differentiation (Rö nty et al., 2006) , but Western blotting analysis with panpalladin antibodies indicates expression of this isoform also in SMC (Mykkanen et al., 2001) . Hence, at present no cytoskeletal protein allows to reliably discriminate between myofibroblasts and SMC; however, recent advances in proteomics and gene array analysis may lead to the identification of such a unique marker of the myofibroblast, provided that it exists (Chambers et al., 2003; Malmstrom et al., 2004) .
The myofibroblast surface. Of particular interest not only for the purpose of www.jidonline.org 527 B Hinz identification but also for the delivery of specific drugs are proteins specifically expressed on the plasma membrane of myofibroblasts. The membrane protein Thy-1 is frequently used for the inverse approach as it is expressed by fibroblasts but absent from differentiated myofibroblasts (Koumas et al., 2003) . Interestingly, Thy-1-negative cells fail to respond to fibrogenic stimuli suggesting that Thy-1 expression characterizes a specific subpopulation of fibroblasts that may not be able to undergo myofibroblast differentiation (Zhou et al., 2004; Hagood et al., 2005) . A promising new strategy to target and identify myofibroblasts is the expression of specific cadherins (Hinz and Gabbiani, 2003a) , transmembrane cell-cell adhesion proteins that are intracellularly linked to the actin cytoskeleton (Gumbiner, 2005) . In contrast to virtually cadherin-negative fibroblasts of normal dermis, protomyofibroblasts of early granulation tissue and in culture express N-cadherin (cadherin-2, A-cell adhesion molecule (A-CAM)) (Hinz et al., 2004) . In conjunction with the appearance of a-SMA after TGFb1-treatment in culture or in differentiated myofibroblasts of contractile wound granulation tissue, N-cadherin becomes gradually replaced by OB-cadherin (cadherin-11). OB-but not N-cadherin seems to play a functional role in coordinating myofibroblast contraction in populations (Hinz et al., 2004) . A similar shift from N-to OB-cadherin expression has been described in stroma fibroblasts reacting against human prostate cancer progression (Tomita et al., 2000) . OB-cadherin is absent from SMC but it is expressed on a variety of cell types of mesenchymal origin; hence, it cannot be considered as unique myofibroblast surface marker.
The ECM of myofibroblast-populated tissue. In addition to producing tension for remodeling, enhanced ECM synthesizing and processing activity significantly contributes to tissue remodeling. Myofibroblasts produce several components of the ECM that can potentially be used as molecular markers, depending on the context of myofibroblast appearance; the most prominent myofibroblast ECM products are collagens of types I, III, IV, and V (Schurch et al., 2006) which, however, are produced by a variety of cells. More recently, collagen type VI attracted attention as it is upregulated together with myofibroblast differentiation in human renal fibrosis (Groma, 1998) , in myocardial interstitial fibrosis (Kitamura et al., 2001) , and in the stroma of hepatocellular carcinoma (Faouzi et al., 1999) . Interestingly, culturing cardiac fibroblasts on collagen type VI substrates induces myofibroblast differentiation but not culture on collagen types I and III (Naugle et al., 2006) . At present, the most reliable marker of the myofibroblast ECM is the FN splice variant ED-A FN (Serini et al., 1998) . ED-A FN is also expressed in low amounts by fibroblastic cells in culture (Dugina et al., 2001; Hinz et al., 2001a) and by vascular SMC in vivo and in vitro (Glukhova et al., 1989) . Another component of the myofibroblast ECM, glycoprotein tenascin-C is associated with tissue repair phenomena (ChiquetEhrismann and Chiquet, 2003) . Tenascin-C appears to attract fibroblasts and to promote their differentiation into myofibroblast in injured tissue (Tamaoki et al., 2005) and at the tumor invasion front of cancers (De Wever et al., 2004) . However, the shared expression in SMC limits its usage as myofibroblast marker (Chiquet-Ehrismann and Chiquet, 2003) .
In view of the expression profile of cytoskeletal and ECM proteins, the differentiated myofibroblast appears to be situated in a continuous spectrum existing between fibroblasts and SMC. It may be necessary to combine common markers of the contractile cell phenotype with the exclusive surface expression of proteins like OB-cadherin and Thy-1 to unmistakably discriminate between fibroblasts, myofibroblasts, and SMC.
Chemical factors inducing myofibroblast formation
Apart from being important diagnostic tools, myofibroblast-specific proteins are likewise potential targets to modulate myofibroblast differentiation and/ or contractile function; this has been shown by interfering with a-SMA and with ED-A FN (Serini et al., 1998) . Alternative antifibrosis strategies aim to prevent development of tissue contractures by affecting physiological cytokines that control myofibroblast differentiation. TGFb1 is considered the major growth factor directly promoting myofibroblast development by inducing expression of a-SMA (Desmouliere et al., 1993; Ronnov-Jessen and Petersen, 1993) , ECM proteins (Werner and Grose, 2003) , and a number of cytoskeletal proteins that construct the myofibroblast contractile apparatus (Malmstrom et al., 2004) . TGFb1 effects are ''fine-tuned'' by cooperative or antagonistic growth factors and some recent studies report myofibroblast differentiation in the absence of TGFb1 signaling.
Control of a-SMA transcription by TGFb1 signaling. The major pathway through which TGFb1 regulates expression of a-SMA in fibroblastic cells appears to involve Smad signaling ( Figure 1 ). Binding of active TGFb1 to the TGFb receptor type II leads to the phosphorylation and recruitment of TGFb receptor type I into a heteromeric receptor complex. The serine/threonine kinase activity of the activated complex phosphorylates Smad2 and Smad3, that each bind to Smad4 and translocate into the nucleus to enhance gene transcription by cooperating with DNA transcription factors (Feng and Derynck, 2005; Massague et al., 2005) . Transcription of a-SMA in lung myofibroblasts and in myofibroblast-like activated hepatic stellate cells is predominantly mediated by the binding of Smad3 to the Smad-binding element 1 upstream of the a-SMA core promoter sequence; the role of Smad3 binding to a second Smad-binding element (Smad-binding element 2) in the core region is unclear at present (Hu et al., 2003; Uemura et al., 2005) . In contrast, another study demonstrated that overexpression of Smad2 but not of Smad3 induces myofibroblast differentiation in lung fibroblasts (Evans et al., 2003) ; this discrepancy may be due to different roles of Smad2 and Smad3 depending on the level of myofibroblast differentiation (Liu et al., 2003) . Moreover, rather than being essential factors for a-SMA transcription, Smad 2/3 should be considered as modulators of the activity of other transcription factors. This may explain different results obtained from acute removal of Smad, for example, by using an antisense approach compared with chronic Smad deficiency in knockout animals. In the first setting, cells may not be able to compensate for the instant loss of the important modulating activity of Smads; adaptation and compensation may, however, occur in the knockout system.
Alternatively, TGFb1 can regulate fibroblast gene expression independently from Smad signaling (Derynck and Zhang, 2003; Moustakas and Heldin, 2005 ) and expression of a-SMA has been documented during the activation of Smad3-null hepatic stellate cells in culture (Schnabl et al., 2001) . One pathway of Smad-independent TGFb1 induction of the myofibroblastic phenotype has been revealed in Smad3-knockout fibroblasts, transfected with dominant-negative Smad2 and appears to function via activating phosphatidylinositol 3-kinase and the downstream effector p21-activated kinase-2; expression of a-SMA has not been assessed in this study (Wilkes et al., 2005) . Smad-independent transcription of a-SMA in fibroblasts is regulated via the TGFb1 control element (Roy et al., 2001; Tomasek et al., 2005) that together with the TGFb1 hypersensitivity region serves as binding site for the transcriptional activator proteins Sp1/2, members of the family of krü ppel-like factors (Cogan et al., 2002; Subramanian et al., 2004) . Another mandatory element for a-SMA transcription in myofibroblasts and SMC is the MCAT-1 site that is enhanced by binding of the transcription enhancer factor-1 which apparently competes with MCAT-suppressor proteins; the presence of a second MCAT element further upstream of the promoter appears not crucial (Swartz et al., 1998; Carlini et al., 2002) .
Importantly, transcription of a-SMA in SMC differs from fibroblasts by being additionally regulated via serum-response factor binding to CC(A/T)6GG-like sequence motifs (CArG elements) in the promoter region (Hautmann et al., 1997); these elements seem not The major pathway of TGFb1-induced a-SMA expression in myofibroblasts is mediated via Smad3 activation by the TGFb1 receptor complex, leading to Smad3 association with Smad4 and translocation into the nucleus. Smad3 binding to Smadbinding elements in the promoter region regulates a-SMA transcription in conjunction with a variety of transcription factors (TF). Some TGFb1-antagonizing factors like IFN-g operate via activation of YB-1 that inhibits Smad3-enhanced gene transcription and upregulates expression of the inhibitory Smad7. TGFb1-induced, Smad-independent transcription of a-SMA is enhanced by binding of the krü ppel-like factors Sp1/3 to the TGFb1 control element and the TGFb1 hypersensitivity region. Moreover, binding of the TEF-1 to the MCAT-1 element is crucial for a-SMA expression in myofibroblasts and SMCs. In contrast to SMC, interaction of the serum-response factor with CArG elements A, B, C, and D is not mandatory for a-SMA transcription; however, the intronic CArG element regulates a-SMA transcription in both cell types. Please refer to text for details and references.
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to be required for a-SMA transcription in myofibroblasts (Roy et al., 2001) . In contrast, the CArG element in the first intron promoter region has recently been demonstrated to regulate a-SMA transcription in myofibroblasts similar to SMC (Tomasek et al., 2005) . It remains to be shown whether upregulated serum-response factor in response to mechanical stimulation (Wang et al., 2006) however, it is unclear whether endogenous TGFb1 contributes to this effect. It is also conceivable that contraction agonists enhance a-SMA expression by augmenting the level of intracellular stress (Shephard et al., 2004a) .
Myofibroblasts are controlled by the mechanical microenvironment
Despite high levels of active TGFb1 in early wounds (Yang et al., 1999) , expression of a-SMA and enhanced myofibroblast contraction are restricted to the later phases of dermal wound healing. Earlier myofibroblast appearance may be suppressed by antagonistic factors released by inflammatory cells and keratinocytes. Moreover, it becomes increasingly clear that myofibroblast development is profoundly influenced by the mechanical microenvironment, in particular, by the organization and stiffness of the ECM (Hinz and Gabbiani, 2003a) . The level of a-SMA expression in cultured differentiated myofibroblasts increases with increasing matrix rigidity as demonstrated using collagen and polyacrylamide gel substrates of varying stiffness (Arora et al., 1999; Hinz et al., 2003) . Mechanically preventing wound closure by splinting the edges of experimental wounds accelerates expression of a-SMA compared with normally healing wounds; stress release by removing the splint leads to reduced a-SMA expression (Hinz et al., 2001b) . TGFb1 is always present in these conditions; however, the mechanical characteristics of the environment appear to modulate its action to induce either migration or contraction (Grin-nell and Ho, 2002). In addition to wound healing and fibrosis, altered matrix stiffness is increasingly considered as major factor activating stroma myofibroblasts in the vicinity of ''stiff'' tumors and thus feeding back on tumor progression (Paszek et al., 2005) . What mechanical properties display the ECM in a physiological tissue context and how do they change during pathological contracture? During embryonic development, soft tissues are established with an elastic modulus of 100-20,000 Pa, depending on their location and function in the adult organism (Fung, 1993; Discher et al., 2005) ; fibroblasts residing in intact tissues are generally ''stressshielded'' by this ECM (Tomasek et al., 2002) . When the protective matrix structure is lost by injury, fibroblasts experience a dramatically changed mechanical microenvironment and endeavor to re-establish ECM tension by increasing remodeling and synthesizing activity (Eckes and Krieg, 2004; Marenzana et al., 2006) . The stiffness of the provisional ECM of early wounds is comparable with the elastic modulus of B10-100 Pa of newly polymerized collagen gels (Kaufman et al., 2005) , frequently used in vitro models of tissue repair (Grinnell, 2003; Carlson and Longaker, 2004) . Fibroblasts initiated in such gels are devoid of contractile fibers and organize actin filaments in the cortex of the cell body and of dendritic extensions (Tamariz and Grinnell, 2002) . In mechanically restrained gels, tension is gradually increasing and first induces the formation of a-SMA-negative stress fibers (Tamariz and Grinnell, 2002; Marenzana et al., 2006) ; this is similar to the de novo appearance of protomyofibroblast in 5-to 6-day-old rat wound granulation tissue (Hinz et al., 2001b) . Gel and tissue stiffness at this stage have not been measured but neoformation of stress fibers in fibroblasts grown on soft two-dimensional culture substrates occurs at an elastic modulus of B3,000-6,000 Pa (Discher et al., 2005; Yeung et al., 2005) .
Progression to the differentiated myofibroblast requires significantly higher stiffness that begins to develop in anchored collagen gels after 2-3 days of remodeling by proto-myofibroblasts (Hinz, 2006) and after 8-9 days in experimental rat wounds (Hinz et al., 2001b) . The threshold stiffness for de novo expression of a-SMA in stress fibers ranges around 20,000 Pa as demonstrated for contractile wound granulation tissue and for myofibroblasts cultured on elastic substrates (Goffin et al., 2006) . A comparable matrix stiffness of B15,000 Pa activates hepatic stellate cells into a-SMA-positive myofibroblasts in vitro and during development of liver fibrosis in vivo (Wells, 2005) . In other fibrotic tissues and in granulation tissue toward the end of wound healing, a matrix stiffness of greater than 50,000 Pa has been measured (Goffin et al., 2006) ; this significant tissue rigidification by fibrogenic stroma cells is used to localize tumor metastases in situ with improving imaging methods (Greenleaf et al., 2003) .
The mechanisms and intracellular pathways through which tension potentially controls a-SMA transcription have recently been reviewed (Wang et al., 2006) . In addition, a-SMA itself is beginning to be considered as mechano-sensitive protein that only localizes to stress fibers under significant mechanical load; this provides a rapid mechanism to control myofibroblast contractile function (Goffin et al., 2006; Hinz, 2006) . Reducing stress fiber tension by reducing substrate stiffness and by inhibiting myosin contraction leads to the disassembly of a-SMA from stress fibers that persist as bcytoplasmic actin filament bundles. Stress fiber-derived a-SMA accumulates in cytosolic aggregates that resemble short rods (Goffin et al., 2006) . Similar rod-like aggregates of a-SMA have been demonstrated during physiological spreading of suspended myofibroblasts (Clement et al., 2005) , which is characterized by gradually increasing intracellular tension and de novo formation of stress fibers (Hinz et al., 2003) . From these studies, it has been suggested that construction of a-SMApositive stress fibers requires pre-formation of b-cytoplasmic actin bundles; absence of such an organization template seems to leads to cytosolic accumulation of a-SMA. It is conceivable that the a-SMA-specific N-terminal sequence AcEEED contributes to a-SMA mechano-sensitivity as cytoplasmic delivery of this sequence as a peptide similarly induces a-SMA rod formation (Clement et al., 2005) and selectively removes a-SMA from stress fibers (Chaponnier et al., 1995; Hinz et al., 2002) .
How myofibroblasts feel stress
The question remains how myofibroblasts sense the gradually increasing change in matrix stiffness that accompanies tissue remodeling. Three major mechanisms of mechano-sensing are conceivable: (1) mechano-sensitive ion channels in the plasma membrane (Martinac, 2004) , (2) integrin-mediated stress perception (Katsumi et al., 2004) , and (3) geometry changes that reveal cryptic signaling domains in proteins of the ECM (Vogel and Sheetz, 2006 ). Cultured fibroblasts modulate the level of a-SMA expression after locally stretching the plasma membrane with the use of twisting magnetite beads; reaction to these rapid stimuli is thought to depend at least in part on the opening of mechano-sensitive ion channels and influx of Ca 2 þ over the plasma membrane (Ko et al., 2001) . However, myofibroblasts in vivo differentiate in response to matrix changes that occur sometimes over days and months, which demands a ''slow'' mechanosensor. Moreover, fibroblastto-myofibroblast transition can be driven by subtle forces as produced by very slow interstitial flow that accompanies inflammation and tissue regeneration (Ng et al., 2005) ; these physiological mechano-stimuli likely exclude membrane channels as force detection mechanism for myofibroblast differentiation.
The role of cell-matrix adhesions in myofibroblast stress perception. It is widely accepted that to perceive mechanical signals from the ECM, fibroblasts utilize integrin-based matrix adhesions, that is, the same transmembrane organelles that anchor stress fibers to the substrate (Chen et al., 2004; Bershadsky et al., 2006) . Ultrastructural analysis of myofibroblasts in fibrotic and wound granulation tissue www.jidonline.org 531
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has revealed extensive cell-matrix contacts, called fibronexus that are absent from normal connective tissue fibroblasts (Eyden, 2005) . Analogously, cultured myofibroblasts develop specialized focal adhesions (FAs) that have been termed ''supermature FAs'' to account for their significantly longer appearance (8-30 mm) (Dugina et al., 2001) compared with ''classical FAs'' (2-6 mm) of a-SMA-negative fibroblasts (Geiger et al., 2001 ). In addition, supermature FAs exhibit a specific molecular composition by co-expressing high levels of vinculin, paxillin, and tensin and integrins avb3 and a5b1 (Dugina et al., 2001; Hinz et al., 2003) . This is different from classical FAs that generally lack tensin and a5b1 integrin and to fibrillar adhesions that contain tensin and a5b1 integrin but not vinculin, paxillin, and avb3 integrin (Geiger et al., 2001) . More comprehensive reviews of the molecular components of myofibroblast ECM adhesions have recently been published (Hinz and Gabbiani, 2003a; Hinz, 2006) . Moreover, supermature FAs display highly phosphorylated focal adhesion kinase and paxillin, which may play a role in the recruitment of fibrillar adhesion components to classical FAs (Goffin et al., 2006) . Consistently, phosphorylated focal adhesion kinase is central in the adhesion-dependent differentiation of cultured lung (Thannickal et al., 2003) and scleroderma myofibroblast (Mimura et al., 2005) . It remains to be shown whether and how supermature FAs assemble in focal adhesion kinasenull corneal fibroblasts that apparently acquire a constitutive myofibroblast phenotype (Greenberg et al., 2006) . Establishment of supermature FAs depends both on the significant intracellular contractile activity generated by a-SMA and on a stress-resistant ECM (Hinz, 2006) . Differentiated myofibroblasts convert supermature FAs into small classical FAs after administration of the AcEEED peptide (Hinz et al., 2003) and when cultured on soft substrates and in newly polymerized collagen gels (Goffin et al., 2006; Hinz, 2006) . These recent studies suggest that fibroblasts gain information about the mechanical state of the ECM by assessing the level of tension in stress fibers, which is limited by the size of their matrix anchors. Forcing myofibroblasts to grow on arrays of classical FA adhesion islets (p6 mm) leads to the rapid loss of a-SMA ( Figure 2) ; dynamically enlarging these islets on extendable membranes leads to reincorporation of a-SMA into stress fibers. Reincorporation is independent from the magnitude of the applied stretch but requires that the resulting islet size corresponds to supermature FAs (B8 mm). Resizing classical to supermature FAs permits exertion of B4-fold greater stress (Goffin et al., 2006) and provides an exceptionally strong ECM anchor that renders myofibroblasts highly adhesive (Hinz et al., 2003) .
All these data suggest that formation of supermature FAs represents a critical control point in the mechanical feedback loop of extracellular stress and intracellular tension that regulates the state of myofibroblast differentiation (Figure 3) . In physiological tissue repair, this checkpoint could ensure that enhanced myofibroblast contraction only occurs when the tissue has been sufficiently remodeled by proto-myofibroblasts for effective force exertion by differentiated myofibroblasts. It appears difficult to establish whether the primary event is represented by a-SMAgenerated stress fiber tension or FA supermaturation. Nevertheless, specifically targeting supermature FAs is one potential strategy to interrupt the mechanical cycle when it has become vicious in pathological contractures. domains in several type III modules that unfold upon cell traction (Vogel and Sheetz, 2006) . ED-A, one of such modules is spliced into the FN molecule during tissue repair and is a prerequisite for TGFb1-induced myofibroblast differentiation (Serini et al., 1998) . It remains to be shown whether cell-generated mechanical forces may change the availability of this domain for specific integrins to induce myofibroblast-promoting intracellular signals. Another intriguing hypothesis on how increased ECM tension and/or cell traction forces enhance expression of a-SMA is by directly activating TGFb1.
Fibroblasts and myofibroblasts secrete TGFb1 as part of a large latent complex, additionally consisting of the latency-associated protein (LAP) and the latent TGFb1-binding protein (LTBP-1) (Mangasser-Stephan et al., 2001; Koli et al., 2005) . LTBP-1, a member of the fibrillin family strongly links the large latent complex to the ECM via several ECM binding sites (Unsold et al., 2001) . Activation of TGFb1 occurs upon its release from the large latent complex through proteolytic cleavage (e.g. by plasmin) and by the action of thrombospondin-1 (Annes et al., 2003) . In epithelial cells, cell-generated traction via integrins has been proposed as alternative mechanism to activate TGFb1 from the large latent complex. Both, LAP and LTBP-1 contain RGD motifs for the binding of integrins (Keski-Oja et al., 2004) and the epithelial integrin avb6 was shown to activate TGFb1 during development of lung fibrosis and in culture independently of protease activity (Munger et al., 1999; Annes et al., 2004) . Fibroblasts do not express avb6 integrin; however, integrins avb5 and avb3 were shown to bind to LAP-TGFb1 (Ludbrook et al., 2003) and both are involved in TGFb1 activation by fibrogenic systemic sclerosis fibroblasts through a yet unknown mechanism (Asano et al., 2005a, b) . Moreover, the integrin a8b1 was recently shown to strongly interact with LAP-TGFb1 (Lu et al., 2002) and it is upregulated in conjunction with myofibroblast differentiation during heart (Bouzeghrane et al., 2004) , pulmonary, and hepatic fibrosis (Levine et al., 2000) .
TGFb1 activation by avb6 integrin requires ECM binding of LTBP-1 through its N-terminal hinge region (Annes et al., 2004) , suggesting that matrix resistance needs to counteract cell traction in the activation process. Consistently, transformed fibroblasts expressing high levels of latent LAPTGFb1 do not promote fibrosis when implanted into mouse dermis (Campaner et al., 2006) ; this may be due to the lack of association with LTBP-1 and ECM. It is tempting to speculate that the high stress transmitted at myofibroblast adhesions is particularly efficient in activating TGFb1 from a sufficiently organized ECM. This mechanism would provide active TGFb1 only on demand of contractile cells to uphold myofibroblast differentiation during the contraction phase of tissue repair. After injury, inflammatory signals activate fibroblasts to spread into the provisional wound matrix. Local cell remodeling activity leads to gradual increase in global matrix stiffness that counteracts cell traction forces. The resulting formation of small FAs and stress fibers that contain only cytoplasmic actins characterize the proto-myofibroblast. TGFb1 stimulates proto-myofibroblasts to express a-SMA, which at first is not incorporated into stress fibers but organizes in cytoplasmic rod-like structures. Continuing ECM fiber alignment creates larger surfaces for adhesion formation; larger adhesions permit development of stronger stress fibers and generation of higher contractile forces. When adhesion sites grow to the size of supermature FAs, intracellular tension reaches a critical level that allows incorporation of a-SMA into pre-existing stress fibers. The force generated by a-SMA-containing stress fiber is significantly higher compared to cytoplasmic actin stress fibers leading to further FA supermaturation and ECM contraction, thereby establishing a mechanical loop. Myofibroblasts may exit this cycle when the original structure of the ECM is reconstituted and again takes over the mechanical load; stress-released myofibroblasts eventually undergo apoptosis.
www.jidonline.org 533 , 2003) . Similarly, apoptosis is induced by relaxing fibroblast-populated attached collagen gels induces in vitro (Grinnell et al., 1999; Niland et al., 2001) . The intracellular pathways linking stress release to induction of apoptosis are unclear but likely involve cell matrix junctions (Stupack and Cheresh, 2002; Reddig and Juliano, 2005) , that is to say stress perception mechanisms similar to those used to control fibroblast-to-myofibroblast transition.
Furthermore, adhesion-dependent survival signals are transmitted via cell-cell contacts and cadherins (Jamora and Fuchs, 2002; Yap and Kovacs, 2003) and formation of homotypic cadherin junctions is a possible signal of the presence of myofibroblast accumulation in late granulation tissue. Consistently, corneal myofibroblasts in dense culture significantly decrease the expression of a-SMA and de-differentiate into a-SMAnegative fibroblasts; this has been attributed to contact-induced desensitization to TGFb1 (Petridou et al., 2000) . It remains to be investigated whether increased formation of OB-cadherin type junctions affects myofibroblast survival differently from N-cadherintype contacts (Hinz et al., 2004) . The potential involvement of both, specific cell-matrix and cell-cell contacts in regulating myofibroblast survival has the advantage of their extracellular accessibility to drugs.
Concluding remarks
Most efforts to understanding the molecular mechanism of myofibroblast differentiation and function are driven by the motivation to eliminate this cell in pathological tissue contractures. Although this may be difficult to accept from the sentimental point of view of someone who devotes his research to this cell, novel strategies and drugs are indeed needed to specifically counteract myofibroblast action. Inhibiting the pleiotrophic action of profibrotic cytokines such as TGFb1 bears the disadvantage of affecting a multitude of cells that are also involved in tissue repair. One promising antifibrosis approach is interfering with myofibroblast mechano-perception via cell-to-matrix and cell-to-cell adhesions. Just like many human individuals, myofibroblasts work best under stress; stress release leads to instant loss of internal tension -a condition that apparently drives myofibroblasts into suicide.
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